GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » 3-Year EPS without NRI Growth Rate

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) 3-Year EPS without NRI Growth Rate : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk 3-Year EPS without NRI Growth Rate?

PT Diagnos Laboratorium Utama Tbk's EPS without NRI for the six months ended in . 20 was Rp0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate falls into.



PT Diagnos Laboratorium Utama Tbk 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


PT Diagnos Laboratorium Utama Tbk 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Main Laboratory Diagnos Tbk provides laboratory services that includes health support service activities that are managed by both the government and the private sector, such as health laboratories. The company's products and services include Service Home Service, Corporate Service, Clinical Laboratory, Genomics Laboratory, Inspection Package, Homecare Diagnos, and Examination Panel.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Headlines

From GuruFocus

Cvent and Dragoneer to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-29-2021

Cvent CEO & Founder to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-12-2021